questionsmedicales.fr
Composés hétérocycliques
Composés hétéromonocycliques
Pyridines
Acides nicotiniques
Acides nicotiniques : Questions médicales fréquentes
Diagnostic
5
Carence en niacine
Diagnostic médical
Carence en niacine
Symptômes
Carences nutritionnelles
Diagnostic différentiel
Historique alimentaire
Carence en niacine
Symptômes
5
Carence en niacine
Symptômes
Troubles mentaux
Carence en niacine
Dermatite
Carence en niacine
Neuropathie
Carence en niacine
Fatigue
Carence en niacine
Prévention
5
Groupes à risque
Carence en niacine
Suppléments nutritionnels
Carence en niacine
Éducation nutritionnelle
Prévention
Régimes végétariens
Carence en niacine
Traitements
5
Suppléments nutritionnels
Carence en niacine
Effets secondaires
Suppléments de niacine
Complications
5
Complications
Carence en niacine
Système immunitaire
Carence en niacine
Maladies cardiovasculaires
Carence en niacine
Troubles digestifs
Carence en niacine
Troubles psychologiques
Carence en niacine
Facteurs de risque
5
Facteurs de risque
Carence en niacine
Personnes âgées
Carence en niacine
Régimes restrictifs
Carence en niacine
Maladies chroniques
Carence en niacine
Tabagisme
Carence en niacine
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Acides nicotiniques : Questions médicales les plus fréquentes",
"headline": "Acides nicotiniques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Acides nicotiniques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-08-02",
"dateModified": "2026-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Acides nicotiniques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pyridines",
"url": "https://questionsmedicales.fr/mesh/D011725",
"about": {
"@type": "MedicalCondition",
"name": "Pyridines",
"code": {
"@type": "MedicalCode",
"code": "D011725",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Arécoline",
"alternateName": "Arecoline",
"url": "https://questionsmedicales.fr/mesh/D001115",
"about": {
"@type": "MedicalCondition",
"name": "Arécoline",
"code": {
"@type": "MedicalCode",
"code": "D001115",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.547.292"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Clonixine",
"alternateName": "Clonixin",
"url": "https://questionsmedicales.fr/mesh/D003002",
"about": {
"@type": "MedicalCondition",
"name": "Clonixine",
"code": {
"@type": "MedicalCode",
"code": "D003002",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.547.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Étazolate",
"alternateName": "Etazolate",
"url": "https://questionsmedicales.fr/mesh/D004974",
"about": {
"@type": "MedicalCondition",
"name": "Étazolate",
"code": {
"@type": "MedicalCode",
"code": "D004974",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.547.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Acide nicotinique",
"alternateName": "Niacin",
"url": "https://questionsmedicales.fr/mesh/D009525",
"about": {
"@type": "MedicalCondition",
"name": "Acide nicotinique",
"code": {
"@type": "MedicalCode",
"code": "D009525",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.547.475"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nicotinamide",
"alternateName": "Niacinamide",
"url": "https://questionsmedicales.fr/mesh/D009536",
"about": {
"@type": "MedicalCondition",
"name": "Nicotinamide",
"code": {
"@type": "MedicalCode",
"code": "D009536",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.547.530"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "6-Amino-nicotinamide",
"alternateName": "6-Aminonicotinamide",
"url": "https://questionsmedicales.fr/mesh/D015120",
"about": {
"@type": "MedicalCondition",
"name": "6-Amino-nicotinamide",
"code": {
"@type": "MedicalCode",
"code": "D015120",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.547.530.248"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nicorandil",
"alternateName": "Nicorandil",
"url": "https://questionsmedicales.fr/mesh/D020108",
"about": {
"@type": "MedicalCondition",
"name": "Nicorandil",
"code": {
"@type": "MedicalCode",
"code": "D020108",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.547.530.498"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nicéthamide",
"alternateName": "Nikethamide",
"url": "https://questionsmedicales.fr/mesh/D009552",
"about": {
"@type": "MedicalCondition",
"name": "Nicéthamide",
"code": {
"@type": "MedicalCode",
"code": "D009552",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.547.530.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sorafénib",
"alternateName": "Sorafenib",
"url": "https://questionsmedicales.fr/mesh/D000077157",
"about": {
"@type": "MedicalCondition",
"name": "Sorafénib",
"code": {
"@type": "MedicalCode",
"code": "D000077157",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.547.530.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nicéritrol",
"alternateName": "Niceritrol",
"url": "https://questionsmedicales.fr/mesh/D009531",
"about": {
"@type": "MedicalCondition",
"name": "Nicéritrol",
"code": {
"@type": "MedicalCode",
"code": "D009531",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.547.540"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Acide niflumique",
"alternateName": "Niflumic Acid",
"url": "https://questionsmedicales.fr/mesh/D009544",
"about": {
"@type": "MedicalCondition",
"name": "Acide niflumique",
"code": {
"@type": "MedicalCode",
"code": "D009544",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.547.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nimodipine",
"alternateName": "Nimodipine",
"url": "https://questionsmedicales.fr/mesh/D009553",
"about": {
"@type": "MedicalCondition",
"name": "Nimodipine",
"code": {
"@type": "MedicalCode",
"code": "D009553",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.547.570"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Acide pipémidique",
"alternateName": "Pipemidic Acid",
"url": "https://questionsmedicales.fr/mesh/D010876",
"about": {
"@type": "MedicalCondition",
"name": "Acide pipémidique",
"code": {
"@type": "MedicalCode",
"code": "D010876",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.547.635"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Acide piromidique",
"alternateName": "Piromidic Acid",
"url": "https://questionsmedicales.fr/mesh/D010893",
"about": {
"@type": "MedicalCondition",
"name": "Acide piromidique",
"code": {
"@type": "MedicalCode",
"code": "D010893",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.547.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "4-(2-(Trifluorométhyl)phényl)-2,6-diméthyl-5-nitro-1,4-dihydro-nicotinate de méthyle",
"alternateName": "3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester",
"url": "https://questionsmedicales.fr/mesh/D001498",
"about": {
"@type": "MedicalCondition",
"name": "4-(2-(Trifluorométhyl)phényl)-2,6-diméthyl-5-nitro-1,4-dihydro-nicotinate de méthyle",
"code": {
"@type": "MedicalCode",
"code": "D001498",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.547.900"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Acides nicotiniques",
"alternateName": "Nicotinic Acids",
"code": {
"@type": "MedicalCode",
"code": "D009539",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Charley-Lea Pollard",
"url": "https://questionsmedicales.fr/author/Charley-Lea%20Pollard",
"affiliation": {
"@type": "Organization",
"name": "Sydney School of Veterinary Science, Faculty of Science, The University of Sydney, Camden, NSW 2570, Australia."
}
},
{
"@type": "Person",
"name": "Zamira Gibb",
"url": "https://questionsmedicales.fr/author/Zamira%20Gibb",
"affiliation": {
"@type": "Organization",
"name": "Priority Research Centre for Reproductive Science, University of Newcastle, Callaghan, NSW 2308, Australia."
}
},
{
"@type": "Person",
"name": "Aleona Swegen",
"url": "https://questionsmedicales.fr/author/Aleona%20Swegen",
"affiliation": {
"@type": "Organization",
"name": "Priority Research Centre for Reproductive Science, University of Newcastle, Callaghan, NSW 2308, Australia."
}
},
{
"@type": "Person",
"name": "Christopher G Grupen",
"url": "https://questionsmedicales.fr/author/Christopher%20G%20Grupen",
"affiliation": {
"@type": "Organization",
"name": "Sydney School of Veterinary Science, Faculty of Science, The University of Sydney, Camden, NSW 2570, Australia."
}
},
{
"@type": "Person",
"name": "Pawan Faris",
"url": "https://questionsmedicales.fr/author/Pawan%20Faris",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of General Physiology, Department of Biology and Biotechnology \"Lazzaro Spallanzani\", University of Pavia, Pavia, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Nicotinic Acid attenuates Amyloid β",
"datePublished": "2024-05-22",
"url": "https://questionsmedicales.fr/article/38789043",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neuint.2024.105772"
}
},
{
"@type": "ScholarlyArticle",
"name": "Oral Psoriasis Therapies.",
"datePublished": "2024-04-04",
"url": "https://questionsmedicales.fr/article/38796267",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.det.2024.02.013"
}
},
{
"@type": "ScholarlyArticle",
"name": "3D structure of acetolactate synthase explains why the Asp-376-Glu point mutation does not give the same resistance level to different imidazolinone herbicides.",
"datePublished": "2024-08-05",
"url": "https://questionsmedicales.fr/article/39277385",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pestbp.2024.106070"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dissipation Kinetics and Residue Distribution of Imazethapyr in Urdbean (Vigna mungo (L.) Hepper) and Urdbean Field soil and its Effect on soil Microbial Population.",
"datePublished": "2024-08-03",
"url": "https://questionsmedicales.fr/article/39096383",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00128-024-03931-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exploring the influence of invasive weed biochar on the sorption and dissipation dynamics of imazethapyr in sandy loam soil.",
"datePublished": "2024-04-25",
"url": "https://questionsmedicales.fr/article/38664274",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10661-024-12653-8"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétéromonocycliques",
"item": "https://questionsmedicales.fr/mesh/D006573"
},
{
"@type": "ListItem",
"position": 4,
"name": "Pyridines",
"item": "https://questionsmedicales.fr/mesh/D011725"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acides nicotiniques",
"item": "https://questionsmedicales.fr/mesh/D009539"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Acides nicotiniques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Acides nicotiniques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Acides nicotiniques",
"description": "Comment diagnostiquer une carence en acide nicotinique ?\nQuels tests sont utilisés pour évaluer les niveaux de niacine ?\nQuels symptômes indiquent une carence en acide nicotinique ?\nComment différencier une carence en niacine d'autres carences ?\nQuel rôle joue l'historique alimentaire dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D009539#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Acides nicotiniques",
"description": "Quels sont les principaux symptômes d'une carence en niacine ?\nLa carence en niacine peut-elle causer des troubles mentaux ?\nComment la dermatite se manifeste-t-elle en cas de carence ?\nQuels signes neurologiques sont associés à la carence en niacine ?\nLa fatigue est-elle un symptôme courant de carence en niacine ?",
"url": "https://questionsmedicales.fr/mesh/D009539#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Acides nicotiniques",
"description": "Comment prévenir une carence en acide nicotinique ?\nLes groupes à risque de carence en niacine ?\nLes suppléments sont-ils nécessaires pour tout le monde ?\nComment l'éducation nutritionnelle aide-t-elle à prévenir la carence ?\nLes régimes végétariens sont-ils à risque de carence en niacine ?",
"url": "https://questionsmedicales.fr/mesh/D009539#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Acides nicotiniques",
"description": "Comment traiter une carence en acide nicotinique ?\nQuels aliments sont riches en acide nicotinique ?\nLes suppléments de niacine ont-ils des effets secondaires ?\nQuelle est la posologie recommandée pour la niacine ?\nPeut-on obtenir suffisamment de niacine par l'alimentation seule ?",
"url": "https://questionsmedicales.fr/mesh/D009539#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Acides nicotiniques",
"description": "Quelles complications peuvent survenir en cas de carence prolongée ?\nLa carence en niacine peut-elle affecter le système immunitaire ?\nQuels sont les risques cardiovasculaires liés à la carence en niacine ?\nLa carence en niacine peut-elle entraîner des problèmes digestifs ?\nDes complications psychologiques peuvent-elles survenir ?",
"url": "https://questionsmedicales.fr/mesh/D009539#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Acides nicotiniques",
"description": "Quels facteurs augmentent le risque de carence en niacine ?\nLes personnes âgées sont-elles plus à risque ?\nLes régimes restrictifs augmentent-ils le risque de carence ?\nLes maladies chroniques influencent-elles le risque de carence ?\nLe tabagisme est-il un facteur de risque pour la carence en niacine ?",
"url": "https://questionsmedicales.fr/mesh/D009539#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en acide nicotinique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des symptômes cliniques et des tests sanguins mesurant les niveaux de niacine."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les niveaux de niacine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses sanguines spécifiques mesurent les niveaux de niacine et ses métabolites."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une carence en acide nicotinique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, dermatite, diarrhée et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Comment différencier une carence en niacine d'autres carences ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation des symptômes spécifiques et des tests sanguins permettent de faire la distinction."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique alimentaire dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un historique alimentaire peut révéler des déficits en niacine, aidant au diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux symptômes d'une carence en niacine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent dermatite, diarrhée, démence et douleurs abdominales."
}
},
{
"@type": "Question",
"name": "La carence en niacine peut-elle causer des troubles mentaux ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des troubles cognitifs et des changements d'humeur."
}
},
{
"@type": "Question",
"name": "Comment la dermatite se manifeste-t-elle en cas de carence ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dermatite apparaît sous forme de rougeurs et de desquamation, souvent sur les zones exposées."
}
},
{
"@type": "Question",
"name": "Quels signes neurologiques sont associés à la carence en niacine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent confusion, dépression et neuropathie périphérique."
}
},
{
"@type": "Question",
"name": "La fatigue est-elle un symptôme courant de carence en niacine ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue est fréquente et peut être liée à des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Comment prévenir une carence en acide nicotinique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation variée et équilibrée, riche en niacine, aide à prévenir la carence."
}
},
{
"@type": "Question",
"name": "Les groupes à risque de carence en niacine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes malnutries, alcooliques et ayant des troubles digestifs sont à risque."
}
},
{
"@type": "Question",
"name": "Les suppléments sont-ils nécessaires pour tout le monde ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les suppléments ne sont nécessaires que pour ceux qui ont des besoins accrus ou des carences."
}
},
{
"@type": "Question",
"name": "Comment l'éducation nutritionnelle aide-t-elle à prévenir la carence ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle sensibilise aux besoins nutritionnels et encourage une alimentation riche en niacine."
}
},
{
"@type": "Question",
"name": "Les régimes végétariens sont-ils à risque de carence en niacine ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent l'être, mais une planification adéquate peut assurer un apport suffisant."
}
},
{
"@type": "Question",
"name": "Comment traiter une carence en acide nicotinique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des suppléments de niacine et des modifications alimentaires."
}
},
{
"@type": "Question",
"name": "Quels aliments sont riches en acide nicotinique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les viandes, poissons, légumineuses et céréales complètes sont de bonnes sources."
}
},
{
"@type": "Question",
"name": "Les suppléments de niacine ont-ils des effets secondaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets comme des bouffées de chaleur et des troubles gastro-intestinaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie recommandée pour la niacine ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie varie selon l'âge et le sexe, généralement entre 14 et 16 mg par jour."
}
},
{
"@type": "Question",
"name": "Peut-on obtenir suffisamment de niacine par l'alimentation seule ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut fournir suffisamment de niacine pour la plupart des gens."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir en cas de carence prolongée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications graves incluent des troubles neurologiques et des maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "La carence en niacine peut-elle affecter le système immunitaire ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut affaiblir le système immunitaire, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Quels sont les risques cardiovasculaires liés à la carence en niacine ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une carence peut contribuer à des niveaux élevés de cholestérol et à des maladies cardiaques."
}
},
{
"@type": "Question",
"name": "La carence en niacine peut-elle entraîner des problèmes digestifs ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut causer des troubles digestifs comme la diarrhée et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Des complications psychologiques peuvent-elles survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de l'humeur et des problèmes cognitifs peuvent se développer."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de carence en niacine ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation pauvre, l'alcoolisme et certaines maladies digestives augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent avoir des besoins nutritionnels accrus et une absorption réduite."
}
},
{
"@type": "Question",
"name": "Les régimes restrictifs augmentent-ils le risque de carence ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les régimes très restrictifs peuvent entraîner des carences en niacine et autres nutriments."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques influencent-elles le risque de carence ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies chroniques peuvent affecter l'absorption et les besoins en niacine."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque pour la carence en niacine ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut affecter le métabolisme et augmenter le risque de carence."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 24/04/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Sydney School of Veterinary Science, Faculty of Science, The University of Sydney, Camden, NSW 2570, Australia.
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Affiliations :
Priority Research Centre for Reproductive Science, University of Newcastle, Callaghan, NSW 2308, Australia.
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Affiliations :
Priority Research Centre for Reproductive Science, University of Newcastle, Callaghan, NSW 2308, Australia.
Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford OX1 2JD, UK.
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Affiliations :
Sydney School of Veterinary Science, Faculty of Science, The University of Sydney, Camden, NSW 2570, Australia.
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Affiliations :
Laboratory of General Physiology, Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Affiliations :
Laboratory of General Physiology, Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Affiliations :
Empa, Swiss Federal Laboratories for Materials Science and Technology, Biointerfaces, St.Gallen, Switzerland. markus.rottmar@empa.ch.
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University at Buffalo 730 Natural Sciences Complex, Buffalo, NY 14260-3000, USA.
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University at Buffalo 838 Natural Sciences Complex, Buffalo, NY 14260-3000, USA.
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University at Buffalo 826 Natural Sciences Complex, Buffalo, NY 14260-3000, USA.
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University at Buffalo 771 Natural Sciences Complex, Buffalo, NY 14260-3000, USA.
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Affiliations :
Critical Analytics for Manufacturing Personalised-medicine Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore 138602, Singapore, Singapore.
Publications dans "Acides nicotiniques" :
2 publications dans cette catégorie
Affiliations :
Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota; Department of Biochemistry Molecular Biology and BioPhysics, University of Minnesota, Minneapolis, Minnesota.
Publications dans "Acides nicotiniques" :
Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by progressive memory loss and behavioral disorders. The excessive accumulation of amyloid β (Aβ) and the formation of neu...
Oral psoriasis therapies include both older traditional immunosuppressants, such as methotrexate, cyclosporine, and acitretin, as well as newer, more targeted agents, such as apremilast, deucravacitin...
Resistance to ALS-inhibiting herbicides has dramatically increased worldwide due to the persisting evolution of target site mutations that reduce the affinity between the herbicide and the target. We ...
Imazethapyr is the most common herbicide used for weed management in pulses. A field trial was carried out with imazethapyr 10% SL formulation at 100 and 150 g a.i./ha application rates, as pre-and po...
The management of invasive weeds on both arable and non-arable land is a vast challenge. Converting these invasive weeds into biochar and using them to control the fate of herbicides in soil could be ...
Nicotinamide adenine dinucleotide (NAD...
This study comprises the design and synthesis of novel nicotinic acid-based cytotoxic agents with selective inhibitory efficacy against the vascular endothelial growth factor receptor-2 (VEGFR-2). Scr...
One critical parameter in microbial cultivations is the composition of the cultivation medium. Nowadays, the application of chemically defined media increases, due to a more defined and reproducible f...
Since most Paenibacillus cultivation protocols so far described in literature are based on complex ingredients, in this study, a chemically defined medium for an industrially relevant Paenibacillus po...
In this study, a reliable and time-efficient high-throughput methodology was extended to investigate limitations in chemically defined media. The interpretation of online measured respiration activiti...
In silico predictions are now being utilized in drug discovery and design to assess the physicochemical, pharmacokinetics, and safety properties of compounds at the beginning of the drug discovery pro...
The purpose of this study was to explore a promising lead compound designed from 1-piperazine indole hybrid with nicotinic amide and nicotinic acid analogs targeted on...
The physicochemical, safety, pharmacokinetic, and biological activity properties of those molecules were predicted by using ADMETlab 2.0, ACD labs Chem Sketch software version 14.0, Molinspiration sof...
Overall, our findings offer valuable insights into the potential efficacy and safety of these compounds. It appears that almost all of the compounds have successfully passed the pharmacokinetic evalua...
Efficient sampling materials are essential for assessing nicotine levels in vape shops and other settings where nicotine exposures may exist. Two different treatments of Whatman glass fiber type A (GF...